Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) SVP Emily Dreyer sold 14,025 shares of the business’s stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $32.41, for a total value of $454,550.25. Following the completion of the transaction, the senior vice president now owns 27,645 shares of the company’s stock, valued at $895,974.45. This represents a 33.66 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this link.
Trupanion Trading Down 1.5 %
NASDAQ:TRUP opened at $33.58 on Friday. Trupanion, Inc. has a twelve month low of $19.69 and a twelve month high of $57.90. The company has a quick ratio of 1.66, a current ratio of 1.71 and a debt-to-equity ratio of 0.39. The business has a 50 day moving average price of $42.92 and a two-hundred day moving average price of $47.14. The company has a market cap of $1.43 billion, a P/E ratio of -146.00, a price-to-earnings-growth ratio of 6.02 and a beta of 1.70.
Trupanion (NASDAQ:TRUP – Get Free Report) last released its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 EPS for the quarter, missing the consensus estimate of $0.06 by ($0.02). The company had revenue of $337.31 million during the quarter, compared to analyst estimates of $335.41 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. As a group, analysts expect that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.
Institutional Investors Weigh In On Trupanion
Analyst Ratings Changes
Several equities analysts recently issued reports on the company. Stifel Nicolaus decreased their price objective on Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a research report on Thursday, February 20th. Piper Sandler reduced their price target on Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a research report on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $46.60.
Check Out Our Latest Analysis on Trupanion
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Further Reading
- Five stocks we like better than Trupanion
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- 3 Undervalued Stocks You Can Buy at a Discount Now
- What is the NASDAQ Stock Exchange?
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- Why Are Stock Sectors Important to Successful Investing?
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.